Vanda Pharmaceuticals, Inc. (VNDA)
7.45
-0.25
(-3.25%)
USD |
NASDAQ |
Jan 15, 16:00
7.44
-0.01
(-0.13%)
Pre-Market: 08:37
Vanda Pharmaceuticals SG&A Expense (TTM): 214.26M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 9.186M |
| ADMA Biologics, Inc. | 96.37M |
| Eli Lilly & Co. | 10.39B |
| Exelixis, Inc. | 530.03M |
| Axsome Therapeutics, Inc. | 514.57M |